Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lenses [Yahoo! Finance]
Bausch + Lomb Corporation (BLCO)
Company Research
Source: Yahoo! Finance
of enVista Envy vision intraocular lenses (IOL) from the US Food and Drug Administration (FDA). Following the approval, the Canadian company is planning a limited commercial launch in the US in the coming weeks, with a broader launch expected in 2025. The company also reiterated their plan to seek approval for the product in other countries, whilst enVista Envy IOL range received clearance from Health Canada in May. There have been rumours about the potential private equity buyout of Bausch + Lomb. Financial Times has reported a potential joint bid by private equity groups TPG and Blackstone. Adding that the potential bid to consider the company's enterprise value of $11.2bn, including debt. Bausch + Lomb was formed into an independent, publicly traded company as a spinoff from Bausch Health Companies, with the plans being first announced in 2020, with the Bausch + Lomb starting trading in May of 2022. Bausch Health owns a majority (88%) stake in Bausch + Lomb, and has faced sig
Show less
Read more
Impact Snapshot
Event Time:
BLCO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLCO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLCO alerts
High impacting Bausch + Lomb Corporation news events
Weekly update
A roundup of the hottest topics
BLCO
News
- Groupe Dynamite Shares Fall 2% in First Canadian IPO of 2024 [Yahoo! Finance Canada]Yahoo! Finance Canada
- Groupe Dynamite Shares Fall 2% in First Canadian IPO of 2024 [Yahoo! Finance]Yahoo! Finance
- Groupe Dynamite's ‘Canny' IPO to Kick Off More Canadian Deals [BNN Bloomberg (Canada)]BNN Bloomberg
- Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs [Yahoo! Finance]Yahoo! Finance
- Bausch + Lomb Reports More Than 94 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling ProgramsBusiness Wire
BLCO
Earnings
- 10/30/24 - Beat
BLCO
Sec Filings
- 11/1/24 - Form 8-K
- 10/30/24 - Form 10-Q
- 10/30/24 - Form 8-K
- BLCO's page on the SEC website